je.st
news
Tag: treatment
MMC Green Technology-Compact Ballast Water Treatment Systems for the Maritime Industry
2016-09-15 12:29:00| Ship Technology
MMC Green Technology is a Norwegian manufacturer of ballast water management systems (BWMS).
Tags: systems
water
industry
green
Ward Off Wastewater Treatment Woes
2016-09-12 16:10:00| Chemical Processing
Improving ion-exchange-system performance may require a variety of steps
Tags: treatment
ward
wastewater
woes
FDA Accepts Supplemental Biologics License Application, Assigns Priority Review and Grants Breakthrough Therapy Designation to Mercks KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer
2016-09-07 12:45:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Merck Has Also Submitted a Marketing Authorization Application to the European Medicines Agency for KEYTRUDA in the Same Patient Population Submissions Based on Data from KEYNOTE-024 Trial Showing Superior Progression-Free and Overall Survival Compared to Chemotherapy in Patients Whose Tumors Express High Levels of PD-L1 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors express PD-L1, with a PDUFA, or target action, date of Dec. 24, 2016. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
review
application
license
Wyeths Lip Treatment Has Taste-Masked Sunscreen
2016-09-01 09:06:09| Happi Breaking News
Tags: treatment
lip
sunscreen
wyeths
Google DeepMind targets NHS head and neck cancer treatment
2016-08-31 13:28:32| BBC News | Business | UK Edition
Anonymised scans from 700 former cancer patients at a London hospital will be analysed by Google's artificial intelligence division, DeepMind.
Tags: google
head
treatment
cancer
Sites : [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] next »